Skip to main content
. 2013 Dec;15(12):1354–1362. doi: 10.1593/neo.131660

Figure 1.

Figure 1

Target validation of the RNAi screen results. Cell viability in BxPC-3 cells was determined in the presence of erlotinib after knockdown of the individual target genes using four independent silencing sequences or scrambled nonsilencing control siRNAs (siC).